chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715830), concerns a 70-year-old elderly female patient. The patient did not have any medical history and current illness. On 15-Sep-2017, the patient received FLUAD vaccine (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 178302A). On the same day, the patient also received co-suspect PNEUMOVAX (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: N013541 as reported). It was reported that, the patient had 2 vaccines in the same arm (right arm). The arm was sore later that day, which continued to worsen. The subject went to emergency department on 16-Sep-2017. The patient received pain medications and a sling to wear. The reporter assessed the case as non-serious. Significant case correction received with IRD 06-Mar-2018: The causality of the event was changed from related to not related. The case comment was updated. No changes were made in narrative.
Age: 74.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site inflammation, Injection site swelling, Vaccination site pain
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 715931), concerns a 74-year-old, elderly female patient. On 17-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number:178623, expiry date: not reported). On 18--Sep-2017, next day of vaccination, the patient developed slight redness, inflammation and swelling at the site of injection. It was reported that redness was improving. The patient had slight soreness at the vaccination site and had not taken any medications. At the time of this report, the outcome of the events was not reported. The reporter considered the case as non-serious. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Bacterial infection, Localised infection
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 715934, concerns a 72-year-old, elderly male patient. The patient not current illness at the time of vaccination. On 09-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as unknown), route of administration: intramuscular, anatomical location: left arm, batch number: 178901, expiry date: not reported) and PNEUMOVAX (dose: unknown, route of administration: intramuscular, anatomical location: left arm, batch number: N004564 (as reported), expiry date: not reported). On 10-Sep-2017, the next day of vaccination, the patient developed infection in the arm and was taken to the emergency room (ER). The patient was diagnosed with bacterial infection during the ER visit and was given unspecified antibiotics at the hospital. Lab data was unknown. On an unspecified date, the patient had recovered from the event. The reporter assessed the case as non-serious.
Age: 72.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Erythema, Joint effusion, Peripheral swelling
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from  VAERS (VAERS ID: 715950), concerns a 72-year-old, elderly, male patient. The patient's medical history, allergy and concomitant medication were not reported. On 30-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179203 and expiry date: not reported) and PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: N020502, expiry date: not reported). On 02-Oct-2017, after 02 days of vaccination, the patient went to the emergency room with large red patch and swelling (fluid around elbow) on his right arm. No redness around injection site was noted. The patient was instructed to concern with the doctor. At the time of this report, the outcome of the events was not reported. The reporter assessed the events as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Peripheral swelling
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 715961), concerns an 82-year-old, elderly, female patient. The patient had no medical history or current illness. The patient's allergies and concomitant medications were not reported. On 28-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: left arm, batch number: 179002 (reported as 17900Z), route of administration and expiry date: not reported) and PNEUMOVAX (anatomical location: left arm, batch number: N000508, dose, route of administration and expiry date: not reported). On 29-Sep-2017, after 1 day of vaccination, the patient developed redness and swelling from upper arm with elbow to lower arm (10 to 12 inches). On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 79.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716123), concerns a 79-year-old elderly female patient. The patient's current conditions included hypertension and hyperlipidemia. On 05-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml (N/A as reported), route of administration: intramuscular and anatomical location: left arm, batch number: 178802). On the same day, the patient developed a red, swelling warm to touch-radius 4 inches. It was reported that, patient still had reaction until 15-Sep-2017 with redness but swelling went down to 3 inches radius. The patient was suggested to put ice on injection and to take TYLENOL. The patient had recovered from all the events. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716149) concerns an 82-year-old, elderly, female patient. The patient's medical history, allergies and concomitant medications were not reported. On 01-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623, and expiry date: not reported) and PREVNAR 13 (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: S35324 and expiry date: not reported). On the same day, after the vaccination, the patient developed a large red area of about 6 inches at injection site on her right arm, which was warm to touch after about 06 days of vaccination (reported on 02-Oct-2017). At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 84.0
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia, Asthenia, Pain
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716212), concerns an 84-year-old elderly female patient. The patient did not have any medical history and current illnesses. On 18-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178623). On 19-Sep-2017, a day after vaccination, the patient had a complaint of throbbing pain radiating down her elbow with vibration down the body weakness. On 02-Oct-2017, the patient visited emergency department but was not admitted, so no diagnosis or pain origin was discovered. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3
Symptoms: Chills, Diarrhoea, Muscular weakness, Nausea, Pain in extremity
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716217), concerns a 72-year-old, elderly, female patient. The patient's current condition included hypertension (since an unspecified date). The patient had been allergic to erythromycin and penicillin. The patient's concomitant medications were not reported. On 16-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported). On 18-Sep-2017, after about 48 hours of vaccination, the patient experienced nausea, vomiting, diarrhea, aching legs, weakness of legs and hands and severe chills. On an unspecified date in Sep-2017, the patient had recovered from the events (events lasted in about 3 days). The reporter assessed the events as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3
Symptoms: Vomiting
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716217), concerns a 72-year-old, elderly, female patient. The patient's current condition included hypertension (since an unspecified date). The patient had been allergic to erythromycin and penicillin. The patient's concomitant medications were not reported. On 16-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported). On 18-Sep-2017, after about 48 hours of vaccination, the patient experienced nausea, vomiting, diarrhea, aching legs, weakness of legs and hands and severe chills. On an unspecified date in Sep-2017, the patient had recovered from the events (events lasted in about 3 days). The reporter assessed the events as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Asthenia, Chills, Decreased appetite, Fatigue, Myalgia
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716219), concerns a 71-year-old, elderly, female patient. The patient's allergies and concomitant medications were unknown. The patient had no historical conditions and current illness. On 16-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported). On 17-Sep-2017, approximately 24 hours after vaccination, the patient experienced nausea, vomiting, muscle aches, weakness, fatigue, severe chills and loss of appetite, which lasted about one day. On an unspecified date in Sep-2017, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Nausea, Vomiting
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716219), concerns a 71-year-old, elderly, female patient. The patient's allergies and concomitant medications were unknown. The patient had no historical conditions and current illness. On 16-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported). On 17-Sep-2017, approximately 24 hours after vaccination, the patient experienced nausea, vomiting, muscle aches, weakness, fatigue, severe chills and loss of appetite, which lasted about one day. On an unspecified date in Sep-2017, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716298), concerns a 68-year-old, elderly female patient. The patient had no medical history, current illness and lab data. On 01-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (reported as 2), route of administration: unknown, anatomical location: left arm, batch number: 179002 (reported as 1790002), expiry date: not reported). On an unspecified date, within 2 weeks the patient was administered with another dose of FLUAD (explicitly coded as extra dose administered). No adverse events were reported.
Age: 71.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716363), concerns a 71-year-old, elderly, male patient. The patient had no medical history and the concomitant medications were unknown. On 02-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179301 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PNEUMOVAX (route of administration: intramuscular, batch number: N019983, dose, anatomical location and expiry date: not reported). On the same day, the patient experienced red, hot, swollen, pain (entire upper arm) at injection site and went to emergency room. At the time of the report, the outcome of the events (injection site warmth, injection site redness, injection site swelling, injection site pain) was unknown. The reporter assessed the case as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3
Symptoms: Ocular hyperaemia, Urticaria
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716376), concerns a 68-year-old, elderly female patient. The patient had no relevant medical history, current illness and lab data. The concomitant medications included, PRILOSEC, DYAZIDE, DIOVAN, TOPROL and SYNTHROID for unknown indications. On 24-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: unknown, anatomical location: left arm, batch number: 178901, expiry date: not reported). On the same day, approximately 1 to 1.5 hours post vaccination, the patient developed red eyes and hives on face and neck. The patient also ate shellfish after immunization. The patient was treated with BENADRYL 25 mg followed by 50 mg 4 hours later. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLUA3
Symptoms: Bone pain, Paraesthesia, Pyrexia
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716447), concerns a 71-year-old elderly male patient. The patient's current condition included cancer (since an unspecified date), and was treated with unspecified medication. The patient's concomitant medications included Acyclovir, Losartan, Furosemide, Metoprolol and Trazodone for an unknown indication. On 12-Sep-2017, the patient was administered with FLUAD (TIV) (dose:0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179002, expiry date: not reported). On 13-Sep-2017, 1 day after vaccination, the patient developed high fever of 101 degrees Fahrenheit with tingling in his extremities. It was reported that, his bones hurt, and fever worsened, which was lasted for 2 days after vaccination. Upon consultation with MD, he was recommended to seek emergency department if the fever increases. The patient recovered from the events. The reporter assessed this case as non-serious.
Age: 82.0
Sex: F
Vaccine: FLUA3
Symptoms: Injected limb mobility decreased, Muscle disorder, Neuralgia, Pain in extremity
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716580), concerns a 82-year-old, elderly, female patient. The patient's current condition included hypercholesterolemia, hypertension, rheumatoid arthritis and allergy to nystatin (since an unspecified date). The concomitant medications included atorvastatin, metoprolol and lisinopril/HCTZ for an unknown indication (since an unspecified date). On 28-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178601 and expiry date: not reported). On the same day, after vaccination, the patient experienced substantial pain in the arm, followed by partial immobility and limited range of motion in the injection arm. The patient also felt nervous system pain and muscle impairment. At the time of the report, the patient had not recovered from the events (neuralgia, muscle disorder, pain in extremity and injected limb mobility decreased). The reporter assessed the case as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3, PNC13, TDAP
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 716786), concerns a 68-year-old, elderly, female patient. The patient's medical history was unknown, the patient had no known allergies. The concomitant medications were unknown. On 29-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: left arm (left front as reported), batch number: 178901 (reported as S74424), route of administration and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PREVNAR 13 (anatomical location: left arm (left back as reported), dose, route of administration, batch number and expiry date: not reported) and BOOSTRIX (route of administration: intramuscular, anatomical location: left arm (left high), dose, batch number: N47827 and expiry date: not reported). On the same day, after vaccination, the patient's left arm became red and raised which was warm to touch. The area of redness was decreased, the patient was recommended to seek medical attention if redness did not decrease or got worse. On 06-Oct-2017, the patient went to pharmacy to inquire about her vaccination and reaction. The patient's lab data was unknown. At the time of this report, the outcome of the events (injection site erythema, injection site swelling and injection site warmth) was unknown. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 20-Mar-2018: The word "patient" was corrected to "patient's" and medical condition was corrected to medical attention in the narrative. No other changes were made in the narrative.
Age: 90.0
Sex: M
Vaccine: FLUA3, TDAP, VARZOS
Symptoms: Sensory disturbance
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719421) concerning a 90-year-old, elderly male patient. It was reported that, the patient had no relevant medical history, no current illness and no allergies. However, it was also reported that the patient's concomitant medication included TOVIAZ. On 25-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178503, expiry date: not reported). On the same day, the patient was administered with non-company suspect products ADACEL (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: 594SR. expiry date: not reported) and ZOSTAVAX (dose: 1 DF, route of administration: subcutaneous, anatomical location: left arm, batch number: NO12492, expiry date: not reported). On 26-Aug-2017, after 1 day of vaccination, the patient experienced cob web/spider web feeling all along the left side of his face/head and was not constant but it came up the day after vaccination (sensory disturbance). However, it did not prohibit his daily activities, but it was nuisance. It was reported that, the patient made a visit to the primary physician regarding the event. At the time of this report, the patient had not yet recovered from the event (sensory disturbance). The reporter assessed the case as non-serious. Non-significant case correction received with IRD 20-Mar-2018: The narrative statement was corrected.
Age: 71.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719512), concerns a 71-year-old, elderly, female patient. The patient had no medical history and the concomitant medications were not reported. On 06-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), anatomical location: left arm, batch number: 179502, route of administration and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PNEUMOVAX (dose: 1 (as reported), anatomical location: right arm, batch number: N020502, route of administration and expiry date: not reported). On the same day, after vaccination, the patient experienced swelling and pain to right arm, where the PNEUMOVAX was administered and the events were lasted after 3 days. At the time of the report, the patient had recovered from the events (pain in arm and peripheral swelling). The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719535), concerns an 83-year-old, elderly female patient. The patient's medical history, current illness and concomitant medications were not reported. On 12-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number; 179301, expiry date: not reported). On 11-Oct-2017, after 29 days of vaccination, the patient developed pain and difficulty in raising arm. The patient visited physician. At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 81.0
Sex: M
Vaccine: FLUA3, PNC13
Symptoms: Erythema, Peripheral swelling, Rash pruritic
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719595), concerns an 81-year-old, elderly, male patient. The patient had no known allergy (NKDA). The patient's historical condition included benign prostatic hyperplasia (BPH) (unspecified dates). Current conditions included cardiac arrhythmias, hypertension, parkinsonism (since an unspecified dates) and concomitant medication included Multivitamins for an unknown indication. On 05-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178303, and expiry date: not reported) and PREVNAR 13 (dose: 2 (as reported), route of administration: intramuscular, anatomical location: left arm, batch number: S43277 and expiry date: not reported). On the same day, after the vaccinations, the patient's left arm became swollen, red and developed itchy rash which persisted for 7 days. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Sex: M
Vaccine: FLUA3, PNC13
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719618), concerns a 68-year-old, elderly, male patient. The patient's current conditions and concomitant medications were not reported. On 07-Oct-2017, the patient received FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302 and expiry date: not reported). It was reported that, the vaccine was administered wrong (as reported) and the patient also received non-company vaccine PREVNAR 13 (route of administration: intramuscular, anatomical location: unknown, batch number: 537635 as reported, dose and expiry date: not reported). On 09-Oct-2017, after 2 days of vaccination, the patient experienced pain in left arm which describes as hurt like heck when administered. On the same day, the patient experienced pain in left arm which describes as hurt like heck when administered. On the same day, the patient was not able to lift his arm (reported as past naval). The outcome of the events, injection site pain and injected limb mobility decreased was unknown. The reporter assessed this case as non-serious. Non-significant case correction received with IRD on 20-Mar-2018: The event description sentence and the narrative chronology was corrected.
Age: 67.0
Sex: F
Vaccine: FLUA3
Symptoms: Injected limb mobility decreased
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719883), concerns a 67-year-old, elderly female patient. The patient had no known allergy. On 05-Sep-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179001. expiry date: not reported). On the same day, after vaccination, the patient had limited range of motion of left arm and had to use right hand to open the car door. At the time of the report, the patient had not recovered from the event. The reporter assessed the case as non-serious.
Age: 71.0
Sex: M
Vaccine: FLUA3
Symptoms: Injection site bruising, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719924), concerning a 71-year-old, elderly male patient.  The patient had stent insertion on an unspecified date. The patient's concomitant medication included, PLAVIX. On 29-Sep-2017, the patent was administered with FLUAD (dose: 0.5 ml, route of administration: injection (reported as SYR), anatomical location: left arm, batch number: 178902 (reported as 1478902), expiry date: not reported). On 30-Sep-2017, after 1 day of vaccination, the patient developed large bruise on arm where he received flu shot and experienced pain in the arm. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 77.0
Sex: F
Vaccine: FLUA3
Symptoms: Erythema, Induration, Skin warm, Swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719929), concerns a 77-year-old elderly female patient. The patient's medical history was not reported. On 28-Sep-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular and anatomical location: left arm, batch number: 178302A). On 29-Sep-2017, the patient developed redness in large (4 in square) area, which was raised, warm and firm to touch. The outcome of the events was not reported. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Hot flush, Hyperhidrosis, Nasopharyngitis, Tremor
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 719948), concerns a 67-year-old female patient. The patient's medical history was not reported. On 05-Oct-2017, at approximately 12:30pm, the patient was administered with FLUAD (dose: 0.5ml (unk as reported), route of administration: unknown and anatomical location: left arm, batch number: 179101) and PNEUMOVAX (dose: unk as reported, route of administration: unknown and anatomical location: right arm, batch number: N010109). On the same day, at 4:30pm, the patient experienced shakiness, hot flashes and excessive sweating. At 6:00pm, the patient felt better but still had cold. The outcome of the events was recovered. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLUA3
Symptoms: Blister, Pyrexia, Rash
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720017), concerning a 73-year-old, elderly male patient. The patient's medical history and concomitant medications were not reported. On 02-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, batch number; 178801, anatomical location, expiry date: not reported). On 04-Oct-2017, after 2 days of vaccination, the patient developed fever, rash and blisters. It was reported that, the patient made his physician's office visit for the events. At the time of this report, the outcome of the events (fever, rash and blisters) was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Heart rate increased, Muscle spasms, Peripheral swelling, Pyrexia
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720026), concerns an 81-year-old, elderly, female patient. The patient's current conditions included hypertension and elevated cholesterol (since an unspecified date). The patient had no other current illness and no known allergy. The patient's concomitant medications included lisinopril, Atorvastatin, hydrochlorothiazide, Multivitamins and ALEVE for an unknown indication. On 10-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179101 and expiry date: not reported) and PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: M042324, dose: unknown and expiry date: not reported). On 11-Oct-2017, after 1 day of vaccination, the patient experienced fever, fast pulse, cramps in arm and legs and swollen arm with redness. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Sex: M
Vaccine: FLUA3, PNC13
Symptoms: Hypoaesthesia, Muscle twitching
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720168), concerning an 82-year-old, elderly male patient. The patient's historical conditions included: atrial fibrillation and aortic aneurysm. The patient was allergic to penicillin. Concomitant medications included: Atenolol, Warfarin, Simvastatin and Naproxen for an unknown indication. On 09-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: right arm, batch number: 179403, route of administration, expiry date: not reported). On the same day, the patient was administered with PREVNAR 13 (batch number: R49358, anatomical location: left arm, dose, route of administration, expiry date: not reported). On 12-Oct-2017, around 5-6 pm, after 3 days of vaccination, the patient experienced left arm twitching and numbness especially on the hand and fingertips. On 16-Oct-2017, the patient was advised to follow-up with the neurologist. On an unspecified date, the patient made physician's office visit for the events. It was reported that, the symptoms were still same and no other symptoms were present. At the time of this report, the patient was not recovered from the events (muscle twitching and numbness). The reporter assessed the events as non-serious.
Age: 77.0
Sex: M
Vaccine: FLUA3
Symptoms: Abdominal pain, Nausea, Vomiting
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720212), concerns a 77-year-old elderly male patient. The patient's concomitant medications included Citalopram, Simvastatin and Tamsulosin but the patient's medical history was not reported. The patient had no known drug allergies. On 11-Oct-2017, the patient received FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179103 and expiry date: not reported). On 12-Oct-2017, a day after vaccination, the patient experienced nausea, vomiting and abdominal cramps. The patient consulted a physician. However, he was not treated for his cramping. After 2 days of vaccination, the symptoms were much better but still had small amounts of abdominal cramping. The outcome of the events nausea, vomiting was recovered and abdominal cramps was recovering. The reporter assessed this case as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Abdominal discomfort, Chills, Diarrhoea, Flushing, Injection site inflammation
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720342) concerns a 69-year-old elderly female patient. The patient had flu shot in the past but never experienced any adverse effect. The patient was allergic to cephalosporins and sulfa antibiotics. The patient's concomitant medications included levothyroxine, ramipril, omeprazole. On 11-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179301). On 12-Oct-2017, next day of vaccination, the patient experienced chills, facial flushing, stomach upset and diarrhoea. The injection site was also inflamed and warm to touch. Upon contact by the pharmacist, the patient reported that the symptoms had resolved, however stomach upset, and diarrhoea persisted. The outcome of the events was recovered. The reporter assessed the case as non-serious. Non-significant case correction was received with IRD 20-Mar-2018: Case comment was amended with onset latency of the events. No changes were made in the narrative.
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site warmth
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720342) concerns a 69-year-old elderly female patient. The patient had flu shot in the past but never experienced any adverse effect. The patient was allergic to cephalosporins and sulfa antibiotics. The patient's concomitant medications included levothyroxine, ramipril, omeprazole. On 11-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179301). On 12-Oct-2017, next day of vaccination, the patient experienced chills, facial flushing, stomach upset and diarrhoea. The injection site was also inflamed and warm to touch. Upon contact by the pharmacist, the patient reported that the symptoms had resolved, however stomach upset, and diarrhoea persisted. The outcome of the events was recovered. The reporter assessed the case as non-serious. Non-significant case correction was received with IRD 20-Mar-2018: Case comment was amended with onset latency of the events. No changes were made in the narrative.
Age: 77.0
Sex: F
Vaccine: FLUA3
Symptoms: Contusion, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720362), concerns a 77-year-old, elderly, female patient. The patient's medical history and concomitant medications were not reported. On 01-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179402 and expiry date: not reported). On the same day, after vaccination, the area of injection site was swollen and hot to touch. The injection site area remained swollen for 3 days. Later, the swelling went down. The patient also experienced a huge black and blue bruise on her arm, which was in a baseball size. At the time of the report, the outcome of the events (injection site swelling, injection site bruising and injection site warmth) was unknown. The reporter assessed the case as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUA3
Symptoms: Burning sensation, Hypertension, Hypoaesthesia, Injection site pain, Paraesthesia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720371), concerns a 65-year-old, elderly male patient. The patient's current condition included seasonal allergies at the time of vaccination. The patient's concomitant medications included ketorolac ophthalmic solution 0.5 percent, prednisolone ophthalmic solution 1 percent, bupropion ER 150 mg, alprazolam 1 mg for unknown indications, however, it was reported that the patient had no current illness at the time of vaccination. On 13-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 178601, expiry date: not reported). On 14-Sep-2017, evening, the next day of vaccination, the patient developed pain in right shoulder, rash and sores. At the time of report also the patient had soreness in shoulder with pins and needles, burning sensation and numbness on right side of neck and face. The patient took ibuprofen after 2 days of vaccination and neck exercises. The patient consulted a physician and was give TORADOL and cyclobenzaprine. The patient also had high blood pressure for 1 month and was referred for physical therapy. At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUA3
Symptoms: Rash, Skin ulcer
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720371), concerns a 65-year-old, elderly male patient. The patient's current condition included seasonal allergies at the time of vaccination. The patient's concomitant medications included ketorolac ophthalmic solution 0.5 percent, prednisolone ophthalmic solution 1 percent, bupropion ER 150 mg, alprazolam 1 mg for unknown indications, however, it was reported that the patient had no current illness at the time of vaccination. On 13-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 178601, expiry date: not reported). On 14-Sep-2017, evening, the next day of vaccination, the patient developed pain in right shoulder, rash and sores. At the time of report also the patient had soreness in shoulder with pins and needles, burning sensation and numbness on right side of neck and face. The patient took ibuprofen after 2 days of vaccination and neck exercises. The patient consulted a physician and was give TORADOL and cyclobenzaprine. The patient also had high blood pressure for 1 month and was referred for physical therapy. At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 76.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Abdominal pain upper, Asthenia, Chills, Fatigue, Headache
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720429), concerns a 76-year-old, elderly, female patient. The patient's current condition included hypertension, sinus infection and restless leg syndrome (from an unspecified date) and had no allergies. The concomitant medications included BACTRIM for sinus infection, PREMALEX for restless leg syndrome, amoxclav and Losartan for an unknown indication (on an unspecified date). On 29-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration, anatomical location, batch number and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PREVNAR 13 (dose, route of administration, anatomical location, batch number and expiry date: not reported). On 02-Oct-2017, after 4 days of vaccination, the patient experienced stomach ache, headache and felt weak and very tired. It was reported that, the patient lost five pounds at the time when she was not well. Also reported that, the patient experienced single episode of chills and soreness in the arm for about 3 to 4 days. No lab tests were performed to the patient. On 16-Oct-2017, after 15 days of onset of events, the patient had recovered from the events (abdominal pain, lost weight, weakness, pain in extremity, tiredness, headache, malaise and chills). The reporter assessed the case as non-serious.
Age: 76.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Malaise, Pain in extremity, Weight decreased
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720429), concerns a 76-year-old, elderly, female patient. The patient's current condition included hypertension, sinus infection and restless leg syndrome (from an unspecified date) and had no allergies. The concomitant medications included BACTRIM for sinus infection, PREMALEX for restless leg syndrome, amoxclav and Losartan for an unknown indication (on an unspecified date). On 29-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration, anatomical location, batch number and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PREVNAR 13 (dose, route of administration, anatomical location, batch number and expiry date: not reported). On 02-Oct-2017, after 4 days of vaccination, the patient experienced stomach ache, headache and felt weak and very tired. It was reported that, the patient lost five pounds at the time when she was not well. Also reported that, the patient experienced single episode of chills and soreness in the arm for about 3 to 4 days. No lab tests were performed to the patient. On 16-Oct-2017, after 15 days of onset of events, the patient had recovered from the events (abdominal pain, lost weight, weakness, pain in extremity, tiredness, headache, malaise and chills). The reporter assessed the case as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Abdominal discomfort, Cellulitis, Erythema, Feeling abnormal, Induration
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720442), concerns a 69-year-old, elderly, female patient. The patient's current condition included cancer (since an unspecified date in 2012), high cholesterol, hypertension (HTN) and hypothyroidism (since an unspecified date). The patient had no known drug allergies (since an unspecified date). The concomitant medications included Atorvastatin, Irbesartan, Levothyroxine, Tamoxifen, Megestrol, Omega 3, Vitamin D3 and Vitamin B12 for an unknown indication (since an unspecified date). On 13-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 179502 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PNEUMOVAX (dose: 2 (as reported), route of administration: intramuscular, anatomical location: left arm, batch number: N013521 and expiry date: not reported). On the same day, after vaccination, the patient experienced swelling to the left upper arm where PNEUMOVAX was administered. The patient's left arm was very warm to touch and became red with thick, hard red line with an area of 1/8 inch, which separated the health tissue from non-healthy tissue (as reported). On the same day, the patient went to physician and diagnosed with cellulitis. On 14-Oct-2017, the patient treated with Cephalexin and Naproxen. The patient was unable to sleep for two nights. In next-follow-up, it was reported that, the patient was able to sleep, still not feeling better. Subsequently, reported that due to antibiotic treatment the patient stomach got upset and treated with Yogurt which helps the GI flora. No lab tests were performed to the patient. At the time of the report, the patient had not recovered from the events (stomach upset, cellulitis, sleeplessness and feeling bad). The reporter assessed the case as non-serious. Non-significant case correction received with the IRD 20-Mar-2018: The anatomical location of the co-suspect (pneumococcal vaccine) was corrected from right arm to left arm in narrative.
Age: 69.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site swelling, Insomnia, Skin warm
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 720442), concerns a 69-year-old, elderly, female patient. The patient's current condition included cancer (since an unspecified date in 2012), high cholesterol, hypertension (HTN) and hypothyroidism (since an unspecified date). The patient had no known drug allergies (since an unspecified date). The concomitant medications included Atorvastatin, Irbesartan, Levothyroxine, Tamoxifen, Megestrol, Omega 3, Vitamin D3 and Vitamin B12 for an unknown indication (since an unspecified date). On 13-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 179502 and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PNEUMOVAX (dose: 2 (as reported), route of administration: intramuscular, anatomical location: left arm, batch number: N013521 and expiry date: not reported). On the same day, after vaccination, the patient experienced swelling to the left upper arm where PNEUMOVAX was administered. The patient's left arm was very warm to touch and became red with thick, hard red line with an area of 1/8 inch, which separated the health tissue from non-healthy tissue (as reported). On the same day, the patient went to physician and diagnosed with cellulitis. On 14-Oct-2017, the patient treated with Cephalexin and Naproxen. The patient was unable to sleep for two nights. In next-follow-up, it was reported that, the patient was able to sleep, still not feeling better. Subsequently, reported that due to antibiotic treatment the patient stomach got upset and treated with Yogurt which helps the GI flora. No lab tests were performed to the patient. At the time of the report, the patient had not recovered from the events (stomach upset, cellulitis, sleeplessness and feeling bad). The reporter assessed the case as non-serious. Non-significant case correction received with the IRD 20-Mar-2018: The anatomical location of the co-suspect (pneumococcal vaccine) was corrected from right arm to left arm in narrative.